Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

20.55
Delayed Data
As of Jan 16
 -0.11 / -0.53%
Today’s Change
18.00
Today|||52-Week Range
31.94
-10.50%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 36.00, with a high estimate of 43.00 and a low estimate of 18.00. The median estimate represents a +75.18% increase from the last price of 20.55.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.88
Sales
$0.00
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.14%
 
 
 
 
 
 
Growthannually -63.18%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.